Disc Medicine, Inc.

$67.03+4.62%(+$2.96)
TickerSpark Score
50/100
Mixed
80
Valuation
20
Profitability
15
Growth
84
Health
50
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IRON research report →

52-Week Range45% of range
Low $40.00
Current $67.03
High $99.50

Companywww.discmedicine.com

Disc Medicine, Inc. , a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis.

CEO
John D. Quisel
IPO
2020
Employees
94
HQ
Watertown, MA, US

Price Chart

+33.85% · this period
$94.11$69.61$45.12May 20Nov 18May 20

Valuation

Market Cap
$2.56B
P/E
-10.68
P/S
0.00
P/B
3.75
EV/EBITDA
-10.24
Div Yield
0.00%

Profitability

Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
-36.95%
ROIC
-36.92%

Growth & Income

Revenue
$0 · 0.00%
Net Income
$-212,184,000 · -94.03%
EPS
$-6.01 · -51.77%
Op Income
$-236,022,000
FCF YoY
-92.02%

Performance & Tape

52W High
$99.50
52W Low
$40.00
50D MA
$65.71
200D MA
$72.18
Beta
2.14
Avg Volume
526.54K

Get TickerSpark's AI analysis on IRON

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Apr 13, 26Savage William Jacobsell3,531
Apr 13, 26Savage William Jacobsell2,200
Apr 13, 26Franchi Jean M.sell400
Apr 14, 26Franchi Jean M.sell6,257
Mar 2, 26Savage William Jacobsell4,392
Mar 2, 26Savage William Jacobsell2,986
Feb 25, 26Franchi Jean M.sell353
Feb 17, 26Franchi Jean M.sell4,075
Feb 18, 26Franchi Jean M.sell3,397
Feb 18, 26Franchi Jean M.sell3,684

Our IRON Coverage

We haven't published any research on IRON yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate IRON Report →

Similar Companies